| 1 |
35354667 | Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes. | 2022 May 10 |
2 |
| 2 |
27919004 | Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy. | 2017 Jan |
1 |
| 3 |
27403534 | Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation. | 2016 Jul 11 |
1 |
| 4 |
23370736 | Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis. | 2013 |
1 |
| 5 |
23425956 | Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension. | 2013 Jul |
2 |
| 6 |
23608606 | Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension. | 2013 Apr 22 |
1 |
| 7 |
24648895 | Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice. | 2013 Jan |
2 |
| 8 |
20668453 | A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects. | 2010 Oct |
1 |
| 9 |
20826135 | Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells. | 2010 Dec 15 |
1 |
| 10 |
17303473 | Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect? | 2007 Apr |
1 |
| 11 |
17407587 | Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. | 2007 Apr 3 |
2 |
| 12 |
16298156 | Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma. | 2006 |
1 |
| 13 |
16915030 | Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. | 2006 Sep |
1 |
| 14 |
15117841 | Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. | 2004 May 4 |
4 |